The impact of age and gender on papillary thyroid cancer survival.
about
Advances in Lipidomics for Cancer Biomarkers Discovery2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerLong-Term Outcomes Following Therapy in Differentiated Thyroid Carcinoma: NTCTCS Registry Analysis 1987-2012Correlative Studies in Clinical Trials: A Position Statement From the International Thyroid Oncology GroupVariants in the ATM-CHEK2-BRCA1 axis determine genetic predisposition and clinical presentation of papillary thyroid carcinoma.New insights in risk stratification of differentiated thyroid cancer.Tree-based model for thyroid cancer prognostication.Disease-specific mortality and secondary primary cancer in well-differentiated thyroid cancer with type 2 diabetes mellitus.The acceleration in papillary thyroid cancer incidence rates is similar among racial and ethnic groups in the United States.Conditional survival in patients with thyroid cancer.Analysis of age and disease status as predictors of thyroid cancer-specific mortality using the Surveillance, Epidemiology, and End Results database.Optimal Cutoff Age for Predicting Mortality Associated with Differentiated Thyroid CancerPromoter methylation of p16 and RASSF1A genes may contribute to the risk of papillary thyroid cancer: A meta-analysis.Reassessing the NTCTCS Staging Systems for Differentiated Thyroid Cancer, Including Age at Diagnosis.Long-term survival in young women: hazards and competing risks after thyroid cancer.Risk of Thyroid Cancer in Euthyroid Asymptomatic Patients with Thyroid Nodules with an Emphasis on Family History of Thyroid Cancer.An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer.A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessmentAnaplastic Thyroid Carcinoma, Version 2.2015.Rising incidence of thyroid cancer in Serbia.Prognosis of differentiated thyroid cancer in relation to serum thyrotropin and thyroglobulin antibody status at time of diagnosis.Prognosis of papillary thyroid carcinoma in elderly patients after thyroid resection: A retrospective cohort analysis.Immunohistochemical Expression of Estrogen Receptor-α and Progesterone Receptor in Patients with Papillary Thyroid Cancer.Clinicopathological Characteristics and Prognosis of Papillary Thyroid Carcinoma in Naturally Menopausal Women with Various Durations of Premenarche, Reproductive Periods, and Postmenopausal Stages.Optimal differentiated thyroid cancer management in the elderly.Thyroid cancer incidence among Asian immigrants to Ontario, Canada: A population-based cohort study.Upregulation of the ESR1 Gene and ESR Ratio (ESR1/ESR2) is Associated with a Worse Prognosis in Papillary Thyroid Carcinoma: The Impact of the Estrogen Receptor α/β Expression on Clinical Outcomes in Papillary Thyroid Carcinoma Patients.Nodular thyroid disease in the elderly: novel molecular approaches for the diagnosis of malignancy.Racial disparities in papillary thyroid microcarcinoma survival.Predictors for papillary thyroid cancer persistence and recurrence: a retrospective analysis with a 10-year follow-up cohort study.Age-based disparities in the use of total thyroidectomy for papillary thyroid carcinoma.Optimal cut-off age in the TNM Staging system of differentiated thyroid cancer: is 55 years better than 45 years?Comparison of secondary and primary thyroid cancer in adolescents and young adults.Dynamic profile of differentiated thyroid cancer in male and female patients with thyroidectomy during 2000-2013 in China: a retrospective study.Should Age at Diagnosis Be Included as an Additional Variable in the Risk of Recurrence Classification System in Patients with Differentiated Thyroid Cancer.Outcome prediction with the revised American joint committee on cancer staging system and American thyroid association guidelines for thyroid cancer.Differentiated and anaplastic thyroid carcinoma: Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.Prognostic indicators of outcomes in patients with lung metastases from differentiated thyroid carcinoma during long-term follow-up.Tyrosine kinase inhibitors in iodine-refractory differentiated thyroid cancer: experience in clinical practice.Effect of Age on Response to Therapy and Mortality in Patients With Thyroid Cancer at High Risk of Recurrence.
P2860
Q28079507-2719E878-63FC-400F-913F-4AD19C7471E5Q30367068-31308758-F290-4968-B660-97D56F32975EQ33570297-98724AEC-CBBD-4BA8-BC5E-8A44F2925C12Q33587905-649B5BE2-2464-45FB-AE91-CEADD008182FQ33760096-B0F8106E-BE2B-4547-96CA-51DB8BB2B1A3Q33915384-E8FBBDE4-AE20-4159-BF4F-9AA34EBBEADEQ34284704-458D8662-6E70-4BE7-A1C3-37F6958C6053Q34576166-F9EA9BFC-D7C7-4BFF-AE61-5C55733A43E3Q34649492-F5708A5F-5C9E-40BA-AA41-79552C14594FQ34711239-F7F42802-74A0-4634-8B02-0A2ECF02AC44Q34920275-38C68051-708C-4CB8-8F2C-12DF52B67A2FQ35671667-04C44CF1-5072-4906-B90F-63BEED8BA833Q35856673-6DDCB523-73C8-4571-8D83-8851A64B5D2EQ36108073-BFEF94F6-B276-41C8-9B8D-8FFFB0B154FDQ36311582-75B4CE86-C583-4FA6-AD20-C92A7A293A9AQ36660713-2121002E-34FF-47CC-B9A7-8984785E1522Q36683258-1E1BC8CE-41F7-458A-A49B-85342E2045B0Q36716739-4E637871-0E53-4795-898A-0F28E1DB690EQ37179204-5BAF4D99-CC37-42F8-99BA-04239E34F009Q37357638-AA0CDCFC-F49E-476F-BB35-60CB995BC7DFQ37460181-4405247E-EC7F-46A5-BD6B-F75C46F0D142Q37468257-AD344E43-A9FB-44D7-B8DA-204918D844CCQ37562880-2235EC67-E085-4B53-BA6C-5A24DE0D7271Q37710254-A61E7842-987C-4F6D-81EC-C772302C109BQ38396892-3A3E20CD-D437-4B7B-8750-E1C37A1073B0Q38820954-9D2CCC72-C7C4-4DD3-8184-E093FCA0216CQ38998205-0FA80283-5E51-40EE-B8C6-90EE445FFB1EQ39004661-46EE1D5B-6BCE-450A-BFC3-F89612C4222CQ39131126-DF8B4262-256E-43DC-B9AF-724EBA015A6EQ40034319-03F5671C-2336-48E9-AFDA-B72496C268C0Q40229266-D38A5771-D5F2-4924-868B-7FAA300A5B18Q40498172-7EF59296-A76D-4918-97D7-FA6037341022Q45963754-07EBA2BF-449C-44C8-AB71-82E232FCC0EDQ47096687-807E5DB2-70D3-44E7-9684-5B3F076A7A26Q47139487-50896442-5D9E-4049-8745-6B1D99164B6AQ47797352-676C7E96-DD89-4DC4-AB7A-928BABDC29C9Q48088071-9F3A9D0F-2E70-4407-A8CA-7285C71CC7BCQ48252662-31B944EC-BABB-47A5-9831-839A2F655779Q49592440-DA91F09E-8B55-4905-BACA-E810CF5EF303Q50002439-19C1EA73-A95B-4EB8-BBD6-0C71CEC9F6FA
P2860
The impact of age and gender on papillary thyroid cancer survival.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The impact of age and gender on papillary thyroid cancer survival.
@ast
The impact of age and gender on papillary thyroid cancer survival.
@en
type
label
The impact of age and gender on papillary thyroid cancer survival.
@ast
The impact of age and gender on papillary thyroid cancer survival.
@en
prefLabel
The impact of age and gender on papillary thyroid cancer survival.
@ast
The impact of age and gender on papillary thyroid cancer survival.
@en
P2093
P2860
P356
P1476
The impact of age and gender on papillary thyroid cancer survival
@en
P2093
B R Haugen
D L Steward
D Litofsky
D S Cooper
G Nogueras-Gonzalez
J D Brierley
J Jonklaas
P2860
P304
P356
10.1210/JC.2011-2864
P407
P577
2012-04-10T00:00:00Z